Rightscorp Inc
OTC:RIHT
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Rightscorp Inc
OTC:RIHT
|
US |
|
F
|
Form Bio Co Ltd
KOSDAQ:377220
|
KR |
|
E
|
Erayak Power Solution Group Inc
NASDAQ:RAYA
|
CN |
|
Brainstorm Cell Therapeutics Inc
NASDAQ:BCLI
|
US |
|
Premier Health of America Inc
XTSX:PHA
|
CA |
|
A
|
Akbar Indo Makmur Stimec Tbk PT
IDX:AIMS
|
ID |
|
Ikka Holdings Co Ltd
TSE:7127
|
JP |
|
Lefroy Exploration Ltd
ASX:LEX
|
VG |
|
E
|
Exprivia SpA
MIL:XPR
|
IT |
|
Assicurazioni Generali SpA
F:ASG
|
IT |
|
Batulicin Nusantara Maritim Tbk PT
IDX:BESS
|
ID |
|
Tekfen Holding AS
IST:TKFEN.E
|
TR |
|
Almirall SA
F:E2Z
|
ES |
|
I
|
Industrial and Commercial Bank of China Ltd
XBER:ICK
|
CN |
|
P
|
Philip Morris CR as
PSE:TABAK
|
CZ |
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is RIHT's stock price target?
Not Available
RIHT does not have any price targets made by Wall Street professionals.
What is the Revenue forecast for Rightscorp Inc?
Projected CAGR
228%
Over the last 2 years, the compound annual growth rate for Revenue has been -9%. The projected CAGR for the next 1 year is 228%.